Loading...
NPI 1235149220 · Warwick, RI · Diagnostic Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
M Armada is a diagnostic radiology physician provider located in Warwick, Rhode Island. This profile covers 7 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | M Armada |
| Address | 300 Toll Gate Rd |
| City | Warwick |
| State | RI |
| ZIP | 02886 |
| Taxonomy | Diagnostic Radiology Physician |
| NPI Enumerated | August 9, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $319.2K |
| Medicaid | $13.5K |
This provider’s Medicare revenue profile is highly concentrated in breast imaging: the top three Medicare codes (77067, 77063, 77065) account for 90.0% of total Medicare revenue, indicating the practice is focused on screening and diagnostic mammography rather than a broad radiology mix. The dominance of 77067 and 77063 in particular aligns with routine screening and tomosynthesis services rather than general diagnostic radiology procedures.
77067 is the single largest Medicare revenue driver with $196K (61.4% of Medicare revenue) and 1.5K claims; the provider ranks in the 96th national percentile for this code and is described as notably above typical national volume. This rank and volume position the clinician as a high-volume mammography screener relative to peers nationally rather than a marginal participant.
77063 is the second major Medicare contributor with $78.8K (24.7% of Medicare revenue) and 1.5K claims, also in the 96th national percentile and noted as notably above typical national volume. The paired high-volume performance on both 77067 and 77063 suggests the provider delivers both conventional screening mammography and 3D tomosynthesis at scale for Medicare beneficiaries.
Other Medicare codes (77065 at $12.6K / 3.9%, 76642 at $9.8K / 3.1%, 19083 at $8.9K / 2.8%) together make up a small residual share of Medicare revenue and rank in mid-to-high national percentiles but are described as typical or unremarkable volumes. This pattern reinforces a business model centered on screening with ancillary diagnostic ultrasound and biopsy services provided at lower volumes.
On Medicaid, the provider reported $13.5K lifetime revenue, substantially smaller than the Medicare total of $319.2K, indicating Medicare is the dominant payer and the practice operates with a heavy Medicare skew rather than balanced dual-payer billing. Medicaid billing is concentrated in the same breast imaging codes: the top three Medicaid codes account for 100.0% of Medicaid revenue, with 77067 contributing $9.6K (71.6%) and 77063 contributing $3.8K (28.4%), showing the provider’s Medicaid activity mirrors its Medicare service line.
State-level competitiveness for Medicaid is modest: for 77067 the provider ranks #37 of 54 in-state (32nd percentile) and for 77063 ranks #34 of 47 (28th percentile), both characterized as typical, unremarkable volumes. This suggests that while the clinician is a high-volume mammography provider nationally for Medicare, their Medicaid market share in-state is moderate and not dominant.
The provider has an NPI enumeration date of 2006-08-09 (~20 years ago), indicating long tenure in the market which may reflect sustained service provision in breast imaging over time. Long enumeration combined with concentrated mammography billing implies an established, specialty-focused practice rather than a recent entrant or broad multispecialty operation.
Comparing relative scale and concentration across payers, the practice’s operations appear consistently specialized: mammography screening/tomosynthesis codes drive nearly all revenue for both Medicare and Medicaid, and precomputed top-3 shares (90.0% Medicare, 100.0% Medicaid) confirm a narrow service line focus. That concentrated code mix carries implications for competitive strategy and contracting negotiations—the provider’s leverage will be greatest where they demonstrate nationally high volumes for key screening codes but limited where Medicaid market share is only modest.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 1,470 | $130 | $196K |
| 77063 | The provider captures three dimensional images of the breast using X–rays at various angles for routine checkup. He checks for the presence of any abnormality within the breasts. Tomosynthesis… | 1,460 | $50 | $78.8K |
| 77065 | The provider performs X–ray imaging on one breast in a patient with a known lump or suspected cancer and may use specially designed computer software to help identify or diagnose potential… | 130 | $100 | $12.6K |
| 76642 | In this procedure, the provider performs a focused ultrasound of one breast on a limited area. The procedure includes documentation of the images. | 150 | $70 | $9.8K |
| 19083 | Under ultrasound guidance, the provider takes breast tissue percutaneously from a single lesion for biopsy. He may place a localization device at the same time. | 20 | $420 | $8.9K |
| 77066 | The provider performs X–ray imaging on both breasts in a patient with a lump or suspected cancer and may use specially designed computer software to help identify or diagnose potential abnormalities… | 60 | $120 | $7.1K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 150 | $40 | $6.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 7 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 150 | $70 | $9.6K |
| 77063 | The provider captures three dimensional images of the breast using X–rays at various angles for routine checkup. He checks for the presence of any abnormality within the breasts. Tomosynthesis… | 150 | $30 | $3.8K |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 37 | 50 | 450 | $70 | $152.4K |
| 77063 | The provider captures three dimensional images of the breast using X–rays at various angles for routine checkup. He checks for the presence of any abnormality within the breasts. Tomosynthesis… | 34 | 50 | 430 | $30 | $47K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.